Mark Guerin
Director Financiero/CFO en TRAWS PHARMA, INC. .
Fortuna: 48 083 $ al 30/04/2024
Cargos activos de Mark Guerin
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TRAWS PHARMA, INC. | Director Financiero/CFO | 12/02/2016 | - |
| Comptroller/Controller/Auditor | 09/05/2014 | 12/02/2016 | |
| Director de Operaciones | 10/06/2022 | 01/04/2024 |
Historial de carrera de Mark Guerin
Antiguos cargos conocidos de Mark Guerin.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Director Financiero/CFO | 01/01/2009 | 01/12/2011 |
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Corporate Officer/Principal | - | - |
Formación de Mark Guerin.
| DeSales University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Chief Operating Officer | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
- Bolsa de valores
- Insiders
- Mark Guerin
- Experiencia